These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 16343265
21. Potential use of endothelial progenitor cells for regeneration of the vasculature. Yamahara K, Itoh H. Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):17-27. PubMed ID: 19144668 [Abstract] [Full Text] [Related]
24. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies. Kawamoto A, Asahara T. Catheter Cardiovasc Interv; 2007 Oct 01; 70(4):477-84. PubMed ID: 17894361 [Abstract] [Full Text] [Related]
25. The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia. Sekiguchi H, Ii M, Losordo DW. J Cell Physiol; 2009 May 01; 219(2):235-42. PubMed ID: 19115244 [Abstract] [Full Text] [Related]
26. [Application of endothelial progenitor cells in vascular tissue engineering]. Zhao Y, Xu Z, Cai S. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Apr 01; 25(2):476-8. PubMed ID: 18610646 [Abstract] [Full Text] [Related]
27. Enhancement of neovascularization with cord blood CD133+ cell-derived endothelial progenitor cell transplantation. Yang C, Zhang ZH, Li ZJ, Yang RC, Qian GQ, Han ZC. Thromb Haemost; 2004 Jun 01; 91(6):1202-12. PubMed ID: 15175808 [Abstract] [Full Text] [Related]
28. Neuroblast survival depends on mature vascular network formation after mouse stroke: role of endothelial and smooth muscle progenitor cell co-administration. Nih LR, Deroide N, Leré-Déan C, Lerouet D, Soustrat M, Levy BI, Silvestre JS, Merkulova-Rainon T, Pocard M, Margaill I, Kubis N. Eur J Neurosci; 2012 Apr 01; 35(8):1208-17. PubMed ID: 22512253 [Abstract] [Full Text] [Related]
29. LFA-1 and VLA-4 involved in human high proliferative potential-endothelial progenitor cells homing to ischemic tissue. Duan H, Cheng L, Sun X, Wu Y, Hu L, Wang J, Zhao H, Lu G. Thromb Haemost; 2006 Dec 01; 96(6):807-15. PubMed ID: 17139377 [Abstract] [Full Text] [Related]
30. Angiogenic murine endothelial progenitor cells are derived from a myeloid bone marrow fraction and can be identified by endothelial NO synthase expression. Loomans CJ, Wan H, de Crom R, van Haperen R, de Boer HC, Leenen PJ, Drexhage HA, Rabelink TJ, van Zonneveld AJ, Staal FJ. Arterioscler Thromb Vasc Biol; 2006 Aug 01; 26(8):1760-7. PubMed ID: 16728651 [Abstract] [Full Text] [Related]
31. Combination of VEGF(165)/Angiopoietin-1 gene and endothelial progenitor cells for therapeutic neovascularization. Chen F, Tan Z, Dong CY, Li X, Xie Y, Wu Y, Chen X, Guo S. Eur J Pharmacol; 2007 Jul 30; 568(1-3):222-30. PubMed ID: 17553485 [Abstract] [Full Text] [Related]
32. Endothelial progenitor cells: diagnostic and therapeutic considerations. Liew A, Barry F, O'Brien T. Bioessays; 2006 Mar 30; 28(3):261-70. PubMed ID: 16479582 [Abstract] [Full Text] [Related]
33. Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway. Han JK, Lee HS, Yang HM, Hur J, Jun SI, Kim JY, Cho CH, Koh GY, Peters JM, Park KW, Cho HJ, Lee HY, Kang HJ, Oh BH, Park YB, Kim HS. Circulation; 2008 Sep 02; 118(10):1021-33. PubMed ID: 18711014 [Abstract] [Full Text] [Related]
34. Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146+ blood cells. Delorme B, Basire A, Gentile C, Sabatier F, Monsonis F, Desouches C, Blot-Chabaud M, Uzan G, Sampol J, Dignat-George F. Thromb Haemost; 2005 Dec 02; 94(6):1270-9. PubMed ID: 16411405 [Abstract] [Full Text] [Related]
35. Potential implications of vascular wall resident endothelial progenitor cells. Ergün S, Tilki D, Hohn HP, Gehling U, Kilic N. Thromb Haemost; 2007 Nov 02; 98(5):930-9. PubMed ID: 18000595 [Abstract] [Full Text] [Related]
36. A comparison of the tube forming potentials of early and late endothelial progenitor cells. Mukai N, Akahori T, Komaki M, Li Q, Kanayasu-Toyoda T, Ishii-Watabe A, Kobayashi A, Yamaguchi T, Abe M, Amagasa T, Morita I. Exp Cell Res; 2008 Feb 01; 314(3):430-40. PubMed ID: 18083163 [Abstract] [Full Text] [Related]
37. Immunological and regenerative properties of cord blood stem cells. Francese R, Fiorina P. Clin Immunol; 2010 Sep 01; 136(3):309-22. PubMed ID: 20447870 [Abstract] [Full Text] [Related]
38. Therapeutic potential of human umbilical cord-derived stem cells in ischemic diseases. Wu KH, Zhou B, Mo XM, Cui B, Yu CT, Lu SH, Han ZC, Liu YL. Transplant Proc; 2007 Jun 01; 39(5):1620-2. PubMed ID: 17580202 [Abstract] [Full Text] [Related]
39. Magnetic resonance imaging of human endothelial progenitors reveals opposite effects on vascular and muscle regeneration into ischaemic tissues. Gianella A, Guerrini U, Tilenni M, Sironi L, Milano G, Nobili E, Vaga S, Capogrossi MC, Tremoli E, Pesce M. Cardiovasc Res; 2010 Feb 01; 85(3):503-13. PubMed ID: 19797426 [Abstract] [Full Text] [Related]
40. Bone morphogenetic proteins 2 and 4 are selectively expressed by late outgrowth endothelial progenitor cells and promote neoangiogenesis. Smadja DM, Bièche I, Silvestre JS, Germain S, Cornet A, Laurendeau I, Duong-Van-Huyen JP, Emmerich J, Vidaud M, Aiach M, Gaussem P. Arterioscler Thromb Vasc Biol; 2008 Dec 01; 28(12):2137-43. PubMed ID: 18818419 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]